B-Cell Non-Hodgkin Lymphoma-Refractory
3 clinical trials · Condition
◉ Watch B-Cell Non-Hodgkin Lymphoma-Refractory
| Record | Firm | Date |
|---|---|---|
| One Trial to Evaluate the Safety, Tolerability and Efficacy of JCXH-213 in Patients With r/r B-NHL (NCT06618313) | Beijing GoBroad Hospital | 2025-03-27 |
| Targeting CD19/CD20 Dual-targeted Cell in Patients With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma (NCT06395870) | Tianjin Medical University Cancer Institute and Hospital | 2024-05-09 |
| CC-99282 + Rituximab Early Post CART for Non-Hodgkin's Lymphoma (NCT06209619) | Nathan Denlinger | 2024-01-29 |
Track B-Cell Non-Hodgkin Lymphoma-Refractory automatically
Every clearance here is in the API, with alerts when new ones post.